At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CODX Co-Diagnostics, Inc.
Closed 08-12 16:00:00 EDT
1.48
-0.01
-0.67%
盘后1.58
+0.10+6.76%
19:56 EDT
High1.55Low1.46Vol188.38K
Open1.49D1 Closing1.49Amplitude6.04%
Mkt Cap7.81MTradable Cap7.49MTotal Shares5.28M
T/O283.04KT/O Rate3.72%Tradable Shares5.06M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Co-Diagnostics Inc Expected to Post a Loss of $3.00 a Share - Earnings Preview
Reuters  ·  08-12 04:25
Co-Diagnostics Inc Expected to Post a Loss of $3.00 a Share - Earnings Preview
Co-Diagnostics Submits FDA 510(k) Filing for Flu A/B and RSV Point-of-Care Test
Reuters  ·  08-06
Co-Diagnostics Submits FDA 510(k) Filing for Flu A/B and RSV Point-of-Care Test
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
THOMSON REUTERS  ·  08-06
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Co-Diagnostics Holders Exercise 1,702,362 Warrants at USD 1.57 Per Share in Inducement Deal
Reuters  ·  07-31
Co-Diagnostics Holders Exercise 1,702,362 Warrants at USD 1.57 Per Share in Inducement Deal
Co-Diagnostics Schedules Q2 2026 Earnings Release and Webcast
Reuters  ·  07-30
Co-Diagnostics Schedules Q2 2026 Earnings Release and Webcast
Co-Diagnostics Affiliate CoSara Sends Saragene Bundibugyo Ebola Test Kits for Third-party Evaluation
Reuters  ·  07-28
Co-Diagnostics Affiliate CoSara Sends Saragene Bundibugyo Ebola Test Kits for Third-party Evaluation
Co-Diagnostics - Amends Equity Distribution Agreement with Maxim Group for Common Stock Sale - SEC Filing
THOMSON REUTERS  ·  07-28
Co-Diagnostics - Amends Equity Distribution Agreement with Maxim Group for Common Stock Sale - SEC Filing
Co-Diagnostics Amends Maxim Equity Distribution Agreement, Removes Aggregate Sales Cap
Reuters  ·  07-28
Co-Diagnostics Amends Maxim Equity Distribution Agreement, Removes Aggregate Sales Cap
Co-Diagnostics' India Joint Venture Launches Clinical Studies for Tuberculosis Test
MT Newswires Live  ·  07-22
Co-Diagnostics' India Joint Venture Launches Clinical Studies for Tuberculosis Test
Co-diagnostics - Co-dx Pcr Platform Products to be Manufactured and Distributed in India Under Cosara Brand
THOMSON REUTERS  ·  07-22
Co-diagnostics - Co-dx Pcr Platform Products to be Manufactured and Distributed in India Under Cosara Brand
Co-diagnostics Joint Venture Cosara Initiates Clinical Studies in India for Tuberculosis Test on Pcr Platform
THOMSON REUTERS  ·  07-22
Co-diagnostics Joint Venture Cosara Initiates Clinical Studies in India for Tuberculosis Test on Pcr Platform
Co-diagnostics Announces Annual Shareholder Meeting
Reuters  ·  07-21
Co-diagnostics Announces Annual Shareholder Meeting
Co-diagnostics Names Wes Lindsey Chief Scientific Officer
Reuters  ·  07-16
Co-diagnostics Names Wes Lindsey Chief Scientific Officer
Co-diagnostics Appoints Wes Lindsey, Phd, MBA as Chief Scientific Officer
THOMSON REUTERS  ·  07-16
Co-diagnostics Appoints Wes Lindsey, Phd, MBA as Chief Scientific Officer
Co-diagnostics Announces Annual Shareholder Meeting
Reuters  ·  07-10
Co-diagnostics Announces Annual Shareholder Meeting
NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am
Reuters  ·  07-01
NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am
Co-diagnostics Completes Studies Ahead of Planned Q3 2026 FDA Filing for Flu/rsv Point-of-care PCR Test
Reuters  ·  07-01
Co-diagnostics Completes Studies Ahead of Planned Q3 2026 FDA Filing for Flu/rsv Point-of-care PCR Test
Co-diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-care Test
THOMSON REUTERS  ·  07-01
Co-diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-care Test
Co-Diagnostics hosts Saudi joint venture CoMira for automated manufacturing line unveiling in Utah
Reuters  ·  06-18
Co-Diagnostics hosts Saudi joint venture CoMira for automated manufacturing line unveiling in Utah
Co-Diagnostics Signs Exclusive Distribution Deal With Mexican Partner; Shares Rise Pre-Bell
MT Newswires Live  ·  06-11
Co-Diagnostics Signs Exclusive Distribution Deal With Mexican Partner; Shares Rise Pre-Bell

Introduction

Company Name.
Co-Diagnostics, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Issue price:
--